GDRX insider disclosures
Explore public SEC filings by reporting investor and stock. Filings can appear after the activity they describe. Joint filing lines link to each reporting owner’s profile.
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source | Follow |
|---|---|---|---|---|---|---|---|
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 45412 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on August 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. | 2026-11-15 | 2026-11-16 | 4,541 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 23730 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. | 2026-11-15 | 2026-11-16 | 2,637 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 3373 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on August 15, 2023 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. | 2026-11-15 | 2026-11-16 | 1,686 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 21776 · Securities delivered or withheld for tax or exercise payment | 2026-11-15 | 2026-11-16 | 2,311 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 24087 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. | 2026-11-15 | 2026-11-16 | 4,541 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 19546 · Securities delivered or withheld for tax or exercise payment | 2026-11-15 | 2026-11-16 | 1,342 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 20888 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. | 2026-11-15 | 2026-11-16 | 2,637 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 18251 · Securities delivered or withheld for tax or exercise payment | 2026-11-15 | 2026-11-16 | 858 shares/units | SEC 4 | Follow |
| Chan Thomas (TC) Chief Accounting Officer · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 19109 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. | 2026-11-15 | 2026-11-16 | 1,686 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 174354 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/12 of the award in quarterly installments on November 15, 2026 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 15,850 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 25568 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/8 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 25,567 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 57527 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on May 15, 2025 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,392 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 12848 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · This restricted stock units award vests with respect to 1/16 of the award in quarterly installments on August 15, 2023 and on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through each applicable vesting date. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,424 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 101202 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,951 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 108153 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 15,850 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 92303 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 11,212 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 103515 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 25,567 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 77948 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 2,803 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 80751 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,392 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Class A Common Stock · Direct ownership · Reported balance after transaction: 74359 · Securities delivered or withheld for tax or exercise payment · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 2,817 shares/units | SEC 4 | Follow |
| Fengler Justin See Remarks · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 77176 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · Chief Financial Officer and Chief Strategy & Operations Officer | 2026-11-15 | 2026-11-16 | 6,424 shares/units | SEC 4 | Follow |
| Bruehlman Ronald E Director · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Deferred Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 21692 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). | 2026-11-08 | 2026-11-09 | 21,692 shares/units | SEC 4 | Follow |
| Bruehlman Ronald E Director · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 229044 · The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2026. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). | 2026-11-08 | 2026-11-09 | 21,692 shares/units | SEC 4 | Follow |
| Bezdek Trevor Director · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Restricted Stock Unit · Derivative security · Direct ownership · Reported balance after transaction: 69950 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. · The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 2, 2026, subject to continued service through the applicable vesting date. | 2026-11-02 | 2026-11-03 | 34,975 shares/units | SEC 4 | Follow |
| Bezdek Trevor Director · GoodRx Holdings, Inc. | GDRX GoodRx Holdings, Inc. | Exercise or conversionFiling detailsSEC transaction code M Class A Common Stock · Direct ownership · Reported balance after transaction: 378785 · Each restricted stock unit represents a contingent right to receive one share of Class A common stock. | 2026-11-02 | 2026-11-03 | 34,975 shares/units | SEC 4 | Follow |
Form 4 buy and sell codes cover open-market or private transactions. Form 13F shows quarterly reported holdings. Position changes can have causes other than trading. Disclosures are delayed and provided for research.